Efficacy of solifenacin on symptom bother and health-related quality of life in patients with acute, early chronic, and late chronic overactive bladder: Secondary analysis of data from the VOLT study

被引:1
|
作者
Lucente, Vincent [1 ]
Ostergard, Donald R. [2 ]
Davila, Willy [3 ]
He, Weizhong [4 ]
Gilmet, Gregory P. [4 ]
Forero-Schwanhaeuser, Sergio [5 ]
机构
[1] Institute for Female Pelvic Medicine and Reconstructive Surgery, Park Professional Bldg, 2200W Hamilton St, Allentown, PA 18104, United States
[2] Department of Obstetrics and Gynecology, University of California, Irvine School of Medicine, Irvine, CA, United States
[3] Department of Gynecology, Cleveland Clinic Florida, Weston, FL, United States
[4] Astellas Pharma Global Development, Inc, Deerfield, IL, United States
[5] GlaxoSmithKline, King of Prussia, PA, United States
来源
关键词
D O I
10.1097/SPV.0b013e3181ff28f9
中图分类号
学科分类号
摘要
引用
收藏
页码:320 / 326
相关论文
共 50 条
  • [1] Efficacy of Solifenacin on Symptom Bother and Health-Related Quality of Life in Patients With Acute, Early Chronic, and Late Chronic Overactive Bladder: Secondary Analysis of Data From the VOLT Study (vol 16, pg 320, 2010)
    Lucente, V
    Ostergard, D. R.
    Davila, G. W.
    He, W.
    Gilmet, G. P.
    Ferero-Schwanhaeuser, S.
    [J]. FEMALE PELVIC MEDICINE AND RECONSTRUCTIVE SURGERY, 2011, 17 (02): : 107 - 107
  • [2] Solifenacin for overactive bladder with incontinence: Symptom bother and health-related quality of life outcomes
    Garely, Alan D.
    Lucente, Vincent
    Vapnek, Jonathan
    Smith, Neila
    [J]. ANNALS OF PHARMACOTHERAPY, 2007, 41 (03) : 391 - 399
  • [3] Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder: The VESIcare Open-Label Trial (VOLT)
    Garely, Alan D.
    Kaufman, Joel M.
    Sand, Peter K.
    Smith, Nella
    Andoh, Masakazu
    [J]. CLINICAL THERAPEUTICS, 2006, 28 (11) : 1935 - 1946
  • [4] Relationships between symptoms, symptom bother, and health-related quality of life in patients with overactive bladder taking solifenacin or placebo in the VIBRANT study
    Crosby, R. D.
    Mathias, S. D.
    Marshall, T. S.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2011, 65 (02) : 211 - 218
  • [5] Characterization of Symptom Bother and Health-related Quality of Life in Japanese Female Patients With Overactive Bladder
    Gotoh, Momokazu
    Kobayashi, Toshimitsu
    Sogabe, Keizo
    [J]. NEUROUROLOGY AND URODYNAMICS, 2015, 34 (08) : 730 - 735
  • [6] IMPACT OF SOLIFENACIN ON SYMPTOM BOTHER, HEALTH-RELATED QUALITY OF LIFE, WORK PRODUCTIVITY, TREATMENT SATISFACTION, AND SYMPTOMS IN PATIENTS WITH OVERACTIVE BLADDER: RESULTS FROM VIBRANT
    Mitcheson, H. D.
    Roy, J. B.
    Gilmet, G.
    Marshall, T. S.
    Shannon, J. B.
    [J]. VALUE IN HEALTH, 2009, 12 (03) : A201 - A201
  • [7] RELATIONSHIPS BETWEEN CHANGES IN OVERACTIVE BLADDER (OAB) SYMPTOMS AND IN SUBJECTIVE ASSESSMENTS OF SYMPTOM BOTHER AND HEALTH-RELATED QUALITY OF LIFE (HRQL) IN PATIENTS TAKING SOLIFENACIN OR PLACEBO IN THE VIBRANT STUDY
    Crosby, R. D.
    Mathias, S. D.
    Marshall, T.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 249 - 250
  • [8] Overactive bladder symptom bother and health-related quality of life in patients with systemic lupus erythematosus and primary Sjogren syndrome
    Pereira e Silva, R.
    Romao, V. C.
    Neves, M.
    Garcia, R.
    Oliveira, S.
    Brites, J.
    Oliveira Ramos, F.
    Canhao, H.
    Palma dos Reis, J.
    Pereira da Silva, J. A.
    Lopes, T.
    [J]. LUPUS, 2019, 28 (01) : 27 - 33
  • [9] CHARACTERIZATION OF SYMPTOM BOTHER, HEALTH-RELATED QUALITY OF LIFE, AND PATIENT'S SATISFACTION TO BLADDER CONDITION IN 967 JAPANESE FEMALE PATIENTS WITH OVERACTIVE BLADDER
    Gotoh, M.
    Kobayashi, T.
    Sogabe, K.
    [J]. NEUROUROLOGY AND URODYNAMICS, 2013, 32 (06) : 851 - 852
  • [10] Health-related quality of life in patients with overactive bladder: Results from the ABLE study
    Chancellor, Michael B.
    Aronstein, William S.
    Kianifard, Farid
    Ebinger, Ursula
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2007, 14 (06): : 1093 - 1093